SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

November 22, 2011 08:35 ET

MMRGlobal Schedules Shareholder Chat Tuesday, November 29, 2011, 1:15 p.m. PT

LOS ANGELES, CA--(Marketwire - Nov 22, 2011) - MMRGlobal, Inc. (OTCBB: MMRF), a leading provider of Personal Health Records (, MyEsafeDepositBox storage solutions ( and electronic document management and imaging systems for healthcare professionals (, today announced it will host a shareholder "Chat," scheduled for Tuesday, November 29, 2011, at 1:15 p.m. Pacific Time/4:15 p.m. Eastern Time. Robert H. Lorsch, Chairman and Chief Executive Officer, and Ingrid Safranek, Chief Financial Officer, will discuss recent announcements and transactions the Company has made and answer questions from stockholders.

"There is nothing more exciting in today's financial markets than what is going on in healthcare and specifically Health IT," said CFO Ingrid Safranek. "That's why we are inviting you to learn about how the future of healthcare is at work today at MMR. This will give you an opportunity to get an update from management and ask any questions you may have." Although there will be a live Q&A session on the call, the Company is encouraging shareholders and other interested parties to submit questions in advance to to make sure all the questions are answered in an expedient manner.

MMR will answer questions about several of the Company's recent announcements, including its relationship with UST Global®, a leading provider of end-to-end IT services and solutions for Global 1000 companies. UST is working with MMRGlobal to sell the Company's MyMedicalRecords Personal Health Record and MMRPro document management and imaging system(s) and integrate them with existing and new UST clients.

The Company will also discuss the ng Connect Program, a multi-industry open innovation program founded by Alcatel-Lucent that includes more than 80 members. This includes MMR's participation with ng Connect at the 2012 Consumer Electronics Show being held January 10-13, at the Las Vegas Convention Center, Booth #31412 in the South Upper Hall.

The Company will also answer questions about recent developments regarding its legacy biotech assets and legal settlements resulting in the transfer to MMR of thousands of patient tissue samples and other intellectual property that may be worth millions of dollars in future revenue, and questions about its evolving relationship with JERCS, Inc.

The Company also revealed that MMR Spokesperson Kira Reed will be hosting the Red Carpet at the 80th annual Hollywood Christmas Parade, November 27, 2011, which will be broadcast nationwide on the Hallmark Channel throughout December.

The conference call will be broadcast live over the Internet at or by linking to Investor Relations at You will need to register 15 minutes prior to the start of the call. The call may also be accessed by calling (866)730-5768. Participants should use Passcode 89782329.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (, provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "could," "maintain," "plan," "may," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the evolving relationship between the Company and JERCS, Inc.; the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; variations in our quarterly operating results; litigation matters; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations, including MMRPro; ROI through the MMR Stimulus Program; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; marketing and exploitation of our biotech portfolio; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information